Karen Dawes

Ms. Karen T.
Dawes is an Independent Non-Executive Director at Barinthus Biotherapeutics Plc, an Independent Director at Barinthus Biotherapeutics (UK) Ltd., an Independent Director at Repligen Corp.
and a President at Knowledgeable Decisions LLC.
She is on the Board of Directors at Barinthus Biotherapeutics Plc, Barinthus Biotherapeutics (UK) Ltd., Symbiomix Therapeutics LLC, Repligen Corp., Jones Public Affairs, Inc., Medicines 360 and Seaside Therapeutics LLC.
Ms. Dawes was previously employed as an Independent Director by PaxMedica, Inc., an Independent Non-Executive Director by Medicenna Therapeutics Corp., an Independent Director by Assertio Therapeutics, Inc., a Chairman by PDL BioPharma, Inc., a Senior Vice President & Head-US Business Group by Bayer Corp., a Senior Vice President by Wyeth Pharmaceuticals, Inc., a Chief Commercial Officer & Vice President by Genetics Institute, Inc., a Vice President-Marketing, Pratt Division by Pfizer Inc., and a Senior Vice President-Global Strategic Marketing by Wyeth LLC.
She also served on the board at Inspiration Biopharmaceuticals, Inc., Protein Design Labs, Inc. and Genaissance Pharmaceuticals, Inc. She received her undergraduate degree from Simmons University, a graduate degree from Simmons University and an MBA from Harvard Business School.